← All trials
NCT05650294
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 31, 2023
- Primary completion
- Feb 28, 2023
- Completion date
- Aug 31, 2023
- First posted
- Dec 14, 2022
- Last posted
- Dec 14, 2022
- Enrollment
- 12
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Aker Biomarine Antarctic ASLead sponsor
- BioTeSys GmbHCollaborator
- BioTeSys GmbHOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.